ISB News

Dr. Nathan Price Named NAM Emerging Leader in Health and Medicine Scholar

Nathan Price

The National Academy of Medicine (NAM) today announced ISB’s Dr. Nathan Price as a 2019 Emerging Leader in Health and Medicine Scholar.

NAM’s Emerging Leaders in Health and Medicine Program provides a platform for a new generation of leaders to collaborate with the NAM and its members across generations and fields of expertise to advance science, combat persistent challenges in health and medicine, and spark transformative change to improve health for all.

“This is an incredible honor and opportunity,” Price said. “I look forward to the opportunities for mentorship, collaboration and innovation with fellow Emerging Leader in Health and Medicine scholars, NAM members, and experts spanning various scientific disciplines. I am humbled and thankful to Lee Hood and Gil Omenn for the nomination.”

Individuals named as scholars are early- to mid-career professionals from a wide range of health related fields, from microbiology and surgery to sociology and biomedical engineering. These young leaders are selected by NAM leadership to engage in a variety of activities throughout the National Academies of Sciences, Engineering, and Medicine (National Academies) over a three-year term.

“This is a significant award,” said Dr. Lee Hood, co-founder of ISB and one of only 20 people elected to all three National Academies. “It selects Nathan as one of the 10 outstanding leaders in the U.S. in modern medicine.”

This year’s class begins its term on July 1, 2019. Activities include biannual meetings in Washington, D.C., with NAM leadership; planning an annual Emerging Leaders Forum; participating in National Academies convening activities; publishing NAM Perspectives; and attending the NAM’s annual meeting each October.

In addition to Price, nine other individuals were named 2019 Emerging Leaders in Health and Medicine Scholars. They are:

  • Maria Elena Bottazzi, Ph.D., associate dean, National School of Tropical Medicine, and professor of pediatric tropical medicine and molecular virology and microbiology, Baylor College of Medicine
  • Oluwadamilola “Lola” Fayanju, M.D., M.A., M.P.H.S., assistant professor of surgery, Duke University
  • Ning (Jenny) Jiang, Ph.D., associate professor of biomedical engineering and oncology, University of Texas at Austin
  • Leora Horwitz, M.D., associate professor of population health and medicine, New York University School of Medicine
  • Mark Huffman, M.D., M.P.H., Quentin D. Young Professor of Health Policy and associate professor of preventive medicine and medicine, Northwestern University Feinberg School of Medicine; associate professor of food policy, The George Institute for Global Health; and associate professor of cardiovascular medicine, University of New South Wales
  • Raina Merchant M.D., M.S.H.P., associate vice president, Penn Medicine/Digital Health; and associate professor, department of emergency medicine, University of Pennsylvania
  • Brea Perry, Ph.D., professor of sociology, Indiana University
  • Hassan A. Tetteh, M.D., M.B.A., M.P.A., M.S., chief medical informatics officer, U.S. Navy; and associate professor of surgery, Uniformed Services University of the Health Sciences
  • Jeffrey K. Wickliffe Ph.D., M.S., associate professor, department of global environmental health sciences, Tulane University School of Public Health and Tropical Medicine

Recent Articles

  • the case for masks

    Molecular Biologist Dr. Sui Huang: We Should All Be Wearing Masks

    ISB’s Dr. Sui Huang has been a powerful voice in a growing chorus contending that masks are an effective tool to stop the spread of COVID-19. Huang calls guidelines from the CDC and other public health agencies “unfortunate,” as they sweep aside a potentially powerful measure that could help “flatten the curve.”

  • ISB’s Dr. Nathan Price Inducted into AIMBE’s College of Fellows 

    Dr. Nathan Price has been inducted into the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows. Price was nominated, reviewed, and elected by peers and members of the College of Fellows for his contributions deriving medical and biological insights from large-scale data analysis and network modeling, and translating those insights to society.

  • ISB Fights Coronavirus

    ISB, Partners Launch Trial to Understand, Treat COVID-19

    ISB researchers are on the front lines to understand and treat COVID-19. We have partnered with Swedish Medical Center, Stanford University, Adaptive Biotechnologies, IsoPlexis, and Metabolon — with generous initial support from the MJ Murdock Charitable Trust and the Wilke Family Foundation — to launch a study of Seattle patients who have contracted COVID-19.